Effective Date: 6/14/2021
Receive updates and information about ALS and treatment options from JourneyMate™ through your mobile device. Opt-in by web (https://www.exservan.com/sign-up/) or text START to 85427. Message frequency varies. Message and data rates may apply.
By opting into this service, you consent to receive mobile text alerts using an automatic telephone dialing system. Consent to receive marketing text messages is not required as a condition of purchasing any goods or services. By signing up, you are confirming you are a United States resident over the age of 18.
Text STOP to 85427 to stop receiving messages from JourneyMate™. You will receive a confirmation text.
For additional information, text HELP to 85427 or contact 1-855-457-6968.
AT&T, Sprint, T-Mobile®, Verizon Wireless, Boost, Cricket, MetroPCS, U.S. Cellular, Virgin Mobile, Google Voice, ACS Wireless, Advantage Cellular (DTC Wireless), Appalachian Wireless, Atlantic Tele-Network (ATN), Bandwidth, Bluegrass Cellular, Buffalo Wireless, CableVision, Carolina West Wireless, Cellcom, Copper Valley, C-Spire Wireless (formerly Cellsouth), Cellular One of East Central Illinois, Chariton Valley Cellular, Cross (dba Sprocket), Duet IP, Element Mobile, EpicTouch, GCI Communications, Golden State, Hawkeye (Chat Mobility), Hawkeye (NW Missouri Cellular), i Wireless (IOWA Wireless), Illinois Valley Cellular, Immix (Keystone Wireless / PC Management), Inland Cellular, Mobi PCS (Coral Wireless LLC), Mosaic, MTA Communications, MTPCS / Cellular One (Cellone Nation), Nex-Tech Wireless, Panhandle Telecommunications, Peoples Wireless, Pine Belt Wireless, Pine Cellular, Pioneer, Plateau, Revol Wireless, RINA, SI Wireless/Mobile Nation, SouthernLinc, SRT Wireless, Thumb Cellular, Union Wireless, United, Viaero Wireless, West Central Wireless, Leaco, Nemont/Sagebrush. Mitsubishi Tanabe Pharma America is not liable for delayed or undelivered messages.
We take your privacy seriously. Please visit https://www.mt-pharma-america.com/privacy-policy/ to review our privacy policy.
Do not use if you are allergic to riluzole or to any of its ingredients.
Before using EXSERVAN™, tell your doctor about all the medicines you take and all your health conditions, including if you:
EXSERVAN™ can cause serious side effects, including:
Liver Problems: Cases of liver injury, some fatal, have occurred in patients taking riluzole. Consult your doctor promptly if you experience unexplained nausea, vomiting, stomach (abdominal) pain, fatigue, weight loss (anorexia), jaundice (yellowing of the skin or whites of the eyes), and/or dark urine.
Low White Blood Cell Counts (Neutropenia): Tell your doctor if you develop a fever while taking EXSERVAN™.
Serious Lung Problems (Interstitial Lung Disease): Tell your doctor if you have problems with your lungs or breathing such as dry cough and difficult or labored breathing. Discontinue EXSERVAN™ immediately if you develop interstitial lung disease.
The most common side effects include numbness in the mouth or tongue, muscle weakness, nausea, lung problems, high blood pressure, and stomach (abdominal) pain.
These are not all the possible side effects of EXSERVAN™. Consult your doctor for medical advice about side effects.
To report side effects, contact Mitsubishi Tanabe Pharma America, Inc. at
Use EXSERVAN™ as prescribed. The recommended dosage for EXSERVAN™ is 50 mg taken orally twice daily at least 1 hour before or 2 hours after a meal. Place EXSERVAN™ oral film strip on the top of the tongue where it will adhere and dissolve. Swallow in a normal manner. Do not cut or split the film or take liquids with EXSERVAN™. Do not chew, spit, or talk while EXSERVAN™ is dissolving. Read the Instructions for Use for EXSERVAN™.
EXSERVAN™ (riluzole) is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Please click here to see the full Prescribing Information for EXSERVAN™.